高级检索
当前位置: 首页 > 详情页

miR-30a-3p inhibits the proliferation of liver cancer cells by targeting DNMT3a through the PI3K/AKT signaling pathway

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol, Wuhan Childrens Hosp, Dept Gastroenterol, Wuhan 430016, Hubei, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Wuhan 430016, Hubei, Peoples R China [3]Huazhong Univ Sci & Technol, Dept Lab Med, Wuhan 430016, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol, Clin Res Ctr, Wuhan Childrens Hosp, Tongji Med Coll, Wuhan 430016, Hubei, Peoples R China
出处:
ISSN:

关键词: miRNA-30a-3p DNA methyltransferase 3a liver cancer cell proliferation PI3K/AKT signaling pathway

摘要:
MicroRNAs (miRNAs or miRs) are crucial for normal development and maintenance of homeostasis. Dysregulated miRNA expression contributes to numerous pathological conditions, including cancer tumorigenesis. However, a limited number of studies have examined the regulatory effects of miR-30a-3p in tumorigenesis. Therefore, the present study investigated the mechanistic process of tumorigenesis in liver cancer. The results revealed a high expression of DNA methyltransferase 3a (DNMT3a) and a low expression of miR-30a-3p in HepG2 cells compared with that in the L02 cell line. A luciferase reporter assay demonstrated that DNMT3a is a direct target of miR-30a-3p. In addition, DNMT3a overexpression significantly enhanced cell proliferation, which was reversed by a miR-30a-3p mimic Similarly, the miR-30a-3p mimic blocked DNMT3a-triggered cell cycle processes and apoptosis by attenuating active p-AKT and p-PI3K in HepG2 cells. In summary, the results of the present study demonstrate that miR-30a-3p is essential for cell proliferation regulation via its association with AKT/PI3K signaling in liver cancer. These results provide insight into the molecular mechanism by which miR-30a-3p inhibits liver cancer cell proliferation and provides a foundation for its clinical development and application.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q4 ONCOLOGY
最新[2023]版:
Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Wuhan Childrens Hosp, Dept Gastroenterol, Wuhan 430016, Hubei, Peoples R China [*1]Huazhong Univ Sci & Technol, Wuhan Childrens Hosp, Dept Gastroenterol, Tongji Med Coll, 100 Hongkong Rd, Wuhan 430016, Hubei, Peoples R China
通讯作者:
通讯机构: [1]Huazhong Univ Sci & Technol, Wuhan Childrens Hosp, Dept Gastroenterol, Wuhan 430016, Hubei, Peoples R China [*1]Huazhong Univ Sci & Technol, Wuhan Childrens Hosp, Dept Gastroenterol, Tongji Med Coll, 100 Hongkong Rd, Wuhan 430016, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:1 总访问量:411 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)